Cart
sales@molnova.com
Ophiopogonside A
CAS No. 2423917-90-0
Ophiopogonside A( ——— )
Catalog No. M38294 CAS No. 2423917-90-0
Ophiopogonside A, a natural conpound that could be isolated from ophiopogon japonicas, possesses anti-cancer activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 252 | Get Quote |
|
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameOphiopogonside A
-
NoteResearch use only, not for human use.
-
Brief DescriptionOphiopogonside A, a natural conpound that could be isolated from ophiopogon japonicas, possesses anti-cancer activity.
-
DescriptionOphiopogonside A, a natural conpound that could be isolated from ophiopogon japonicas, possesses anti-cancer activity.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number2423917-90-0
-
Formula Weight516.628
-
Molecular FormulaC26H44O10
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zheng, Haoyuan, et al. Compound extracted from ophiopogon japonicus, method thereof and application of compound in preparing drug for inhibiting tumor cell growth. CN111040002A.
molnova catalog
related products
-
Leucocyanidin
(+)-Leucocyanidin is the isoform of Leucocyanidin, is an active anti-ulcerogenic ingredient was extracted from Litchi Chinensis. Leucocyanidin demonstrates a significant protective effect against Aspirin-induced erosions in rat models.
-
Amoxicillin Sodium
Amoxicillin Sodium is a moderate- spectrum, bacteriolytic, β-lactam antibiotic.
-
Alclofenac
Alclofenac has a significant effect on the acute phase protein response and the degree of L-tryptophan binding to plasma protein and can be used in the treatment of patients with chronic rheumatism.
